Thiele, Anne
Klehr, Lara
Strauß, Sebastian
Angermaier, Anselm
Schminke, Ulf
Kronenbuerger, Martin
Naegel, Steffen
Fleischmann, Robert
Funding for this research was provided by:
Novartis Pharma GmbH Deutschland (Soyka-Förderpreis für Schmerzforschung)
Universitätsmedizin Greifswald
Article History
Received: 29 September 2021
Accepted: 22 November 2021
First Online: 11 December 2021
Declarations
:
: This study was prospectively registered at clinicaltrials.gov (Identifier: NCT04019496) and approved by the ethics committee of the University Medicine Greifswald (Identifier: BB 168/18). All procedures adhered to the <i>Helsinki declaration</i> in its latest revision and were conducted in line with current guidelines for <i>good clinical practice</i> (ICH E6(R2)). All patients and controls were provided detailed study information and gave their written consent for the study and the use of their data.
: Not applicable.
: The author(s) declare(s) that they have no competing interests.